DogeOS Launches Testnet to Bring DeFi Apps to Dogecoin 
SoftBank Shares Fall After $10 Billion OpenAI Investment 
Trump Praises Boeing 737 Max After Flydubai Crash Attempt 
Goldman Sachs Names CATL, Zenergy Top China Battery Picks 
Robinhood Stock Nears $114 as Jobs Data Boosts Risk Appetite 
Flydubai FZ1073 Co-Pilot Accused of Terror Attack 
Coinbase, Circle Stocks Slide as Bank Group Sues OCC Over Crypto Charters 
Airbus Spain Workers Approve Deal to End Months of Strikes 
Chainalysis AI Traces $387M Bitget Hack in Under 10 Minutes 
Disney Plans TV Restructuring With Hundreds of Layoffs 
Zcash Awards $8 Million in Grants After Orchard Bug Crisis 
Nike Stock Slides as Revenue Miss Clouds Turnaround 
MSTR Stock Rises 3% as Strategy Challenges MSCI Bitcoin Stance 
Citi Raises Bitcoin Target to $113,000 as Crypto Outlook Improves 
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal 
Ripple Locks 700 Million XRP Back in Escrow After October Release 
Add as a preferred source on Google
NEW YORK, March 28, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Colorado on behalf of investors who purchased DaVita Inc. (NYSE:DVA) securities between August 5, 2015 and October 21, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/davita-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into needless insurance plans to maximize profits; (2) DaVita was using American Kidney Fund to facilitate these inappropriate practices; (3) therefore DaVita’s revenues and profits were illegally acquired; (4) as a result, DaVita lacked effective internal controls over financial reporting.
On January 6, 2017, the Wall Street Journal published an article revealing that DaVita had received subpoenas from federal prosecutors seeking “the production of information related to charitable premium assistance” in connection with DaVita’s ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis.
If you suffered a loss in DaVita you have until April 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/davita-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
